about
Human Papillomaviruses; Epithelial Tropisms, and the Development of NeoplasiaRole of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune responseViruses and human cancers: a long road of discovery of molecular paradigms.Analysis of longitudinal multivariate outcome data from couples cohort studies: application to HPV transmission dynamics.Human papillomavirus vaccination: the population impact.The distribution of high-risk human papillomaviruses is different in young and old patients with cervical cancerPapillomaviruses use recombination-dependent replication to vegetatively amplify their genomes in differentiated cellsRisk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults.A longitudinal study of human papillomavirus 16 L1, e6, and e7 seropositivity and oral human papillomavirus 16 infectionThe Role of Chlamydia trachomatis in High-Risk Human Papillomavirus Persistence Among Female Sex Workers in Nairobi, Kenya.Serial type-specific human papillomavirus (HPV) load measurement allows differentiation between regressing cervical lesions and serial virion productive transient infections.Short-term natural history of high-risk human papillomavirus infection in mid-adult women sampled monthly.ONCOGENIC HUMAN PAPILLOMAVIRUSES: High-Risk Human Papillomaviruses: Towards a Better Understanding of the Mechanisms of Viral Transformation, Latency and Immune-EscapeNatural Acquired Immunity Against Subsequent Genital Human Papillomavirus Infection: A Systematic Review and Meta-analysis.Population-based prevalence of cervical infection with human papillomavirus genotypes 16 and 18 and other high risk types in Tlaxcala, Mexico.Immunosuppression facilitates the reactivation of latent papillomavirus infections.Viral load and short-term natural history of type-specific oncogenic human papillomavirus infections in a high-risk cohort of midadult women.Episodic detection of human papillomavirus within a longitudinal cohort of young women.Reactivation of Latent HPV Infections After Renal Transplantation.Sequential Acquisition of Anal Human Papillomavirus (HPV) Infection Following Genital Infection Among Men Who Have Sex With Women: The HPV Infection in Men (HIM) Study.Re-detection vs. new acquisition of high-risk human papillomavirus in mid-adult women.Incident Detection of High-Risk Human Papillomavirus Infections in a Cohort of High-Risk Women Aged 25-65 Years.Natural History of HPV Infection across the Lifespan: Role of Viral Latency.High HPV infection prevalence in men from infertile couples and lack of relationship between seminal HPV infection and sperm quality.Recurring infection with ecologically distinct HPV types can explain high prevalence and diversity.High human papillomavirus (HPV) prevalence in South African adolescents and young women encourages expanded HPV vaccination campaigns.Human Papillomavirus: The Equal Opportunity Pathogen.Aging impacts CD103+ CD8+ T cell presence and induction by dendritic cells in the genital tract.Sinecatechins Ointment, 15% for the Treatment of External Genital and Perianal Warts: Proceedings of an Expert Panel Roundtable Meeting.
P2860
Q26801768-5F46BF92-A0A5-468F-96A1-81FB85BCBDB8Q26996330-2E5C4479-D7F8-4A51-90EB-3D4038C36EC3Q30384388-46371402-E600-4A3F-957E-B7E03A85FD72Q30981780-95C49B88-A72D-42A9-9133-9F54A7F44060Q33806566-24166032-8860-4AC1-9530-4835FC74D5D6Q34308427-4A9C8A2E-91A5-4968-9C87-E1C78D1B182EQ34819388-FB9B4EB8-0B8D-40E6-A7BD-E0B274A810B0Q34882577-52FB2911-4E74-400D-83A0-708380960B8CQ34970731-E5EBD5ED-CD5F-45FC-A7A4-6ACD8F51404FQ35619561-415DDD41-7AD2-49F1-A98E-9143563B573DQ36023925-3E3A293C-B62C-406A-9958-AED0BA01E15BQ36116209-409588EC-62B1-4141-B4F0-F920139E8EEAQ36554397-6BEF589F-8256-455A-9D94-2067FC4D5060Q36745242-607298AC-0FA6-48E1-A557-D77800D3F41BQ37224673-E69F4BBA-815A-4B35-9664-CABC85903971Q37547649-272E465C-E807-4E52-A890-13FCF4064FF0Q37626453-3CE1FD5C-2F7F-448F-AFA5-057D506A5DDCQ37840105-BE4784F0-0696-4DFB-8B84-01609949D921Q40397729-7DA5FE5E-8B69-441F-BFF2-02E9B79459F4Q40589093-0C6CD6D7-9EE2-45E8-9877-FBB9A39AB53FQ40603173-6E66CC11-FA76-48A4-ADAE-1968DD4F204DQ40743154-AB67168E-70F0-40F0-AD99-43D103BDB0C0Q41932990-7A2E3AC5-8D42-42B6-8D65-E6FE0BDF0203Q43469953-46155603-30CF-4914-9C1D-0FFCD22CDBA0Q47363184-7EFC7F25-971C-4D1E-8528-F381145814C6Q47559002-2384E897-E695-44AE-B57D-CFB658855A8BQ47867421-5D878312-284A-4DAD-9001-5F75757B1950Q49890273-C239950D-6BC5-454F-A4F3-AA7EA4165A5BQ55238817-B99DC10D-6C4C-49D8-8F78-CC0DDDBA4AC4
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Evidence and impact of human papillomavirus latency.
@ast
Evidence and impact of human papillomavirus latency.
@en
type
label
Evidence and impact of human papillomavirus latency.
@ast
Evidence and impact of human papillomavirus latency.
@en
prefLabel
Evidence and impact of human papillomavirus latency.
@ast
Evidence and impact of human papillomavirus latency.
@en
P2860
P1476
Evidence and impact of human papillomavirus latency.
@en
P2093
Patti E Gravitt
P2860
P304
P356
10.2174/1874357901206010198
P577
2012-12-28T00:00:00Z